Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berit D Nielsen

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Best Practice & Research. Clinical Rheumatology|September 19, 2020
Imaging in large-vessel vasculitisWolfgang A Schmidt, Berit D Nielsen
Best Practice & Research. Clinical Rheumatology|April 3, 2025
Update in imaging for large vessel vasculitisBerit D Nielsen, Luca Seitz, Wolfgang A Schmidt
European Journal of Pharmacology|December 7, 2013
Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteriesElise R Hedegaard, Berit D Nielsen, Susie Mogensen, et al.
Joint Bone Spine|April 22, 2021
Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiationLine L Frølund, Christoffer Våben, Mette Dam, et al.
Joint Bone Spine|September 14, 2021
Answer to Manzo et al. "Early diagnosis in patients with polymyalgia rheumatica: Is a fast track clinic a viable solution?" Joint Bone Spine 2021;88:105262Line L Frølund, Christoffer Våben, Mette Dam, et al.
Rheumatology (Oxford, England)|July 13, 2021
Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologistPeter M Andel, Stavros Chrysidis, Julia Geiger, et al.
Rheumatology (Oxford, England)|March 2, 2022
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: replyPeter M Andel, Stavros Chrysidis, Julia Geiger, et al.
Seminars in Arthritis and Rheumatism|July 9, 2024
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary centerMarc K Nielsen, Andreas W Nielsen, Agnete O Donskov, et al.
Seminars in Arthritis and Rheumatism|July 4, 2026
Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort studyTobias B Kokholm, Andreas W Nielsen, Ib T Hansen, et al.
Frontiers in Medicine|July 19, 2024
The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumaticaBerit D Nielsen, Salome Kristensen, Agnete Donskov, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Best Practice & Research. Clinical Rheumatology|September 19, 2020
Imaging in large-vessel vasculitisWolfgang A Schmidt, Berit D Nielsen
Best Practice & Research. Clinical Rheumatology|April 3, 2025
Update in imaging for large vessel vasculitisBerit D Nielsen, Luca Seitz, Wolfgang A Schmidt
European Journal of Pharmacology|December 7, 2013
Mechanisms involved in increased sensitivity to adenosine A(2A) receptor activation and hypoxia-induced vasodilatation in porcine coronary arteriesElise R Hedegaard, Berit D Nielsen, Susie Mogensen, et al.
Joint Bone Spine|April 22, 2021
Fast track clinic for early diagnosis of polymyalgia rheumatica: Impact on symptom duration and prednisolone initiationLine L Frølund, Christoffer Våben, Mette Dam, et al.
Joint Bone Spine|September 14, 2021
Answer to Manzo et al. "Early diagnosis in patients with polymyalgia rheumatica: Is a fast track clinic a viable solution?" Joint Bone Spine 2021;88:105262Line L Frølund, Christoffer Våben, Mette Dam, et al.
Rheumatology (Oxford, England)|July 13, 2021
Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologistPeter M Andel, Stavros Chrysidis, Julia Geiger, et al.
Rheumatology (Oxford, England)|March 2, 2022
Comment on: Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist: replyPeter M Andel, Stavros Chrysidis, Julia Geiger, et al.
Seminars in Arthritis and Rheumatism|July 9, 2024
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary centerMarc K Nielsen, Andreas W Nielsen, Agnete O Donskov, et al.
Seminars in Arthritis and Rheumatism|July 4, 2026
Predictors of relapse, early escalation and 1-Year use of glucocorticoids in new-onset polymyalgia rheumatica: A prospective cohort studyTobias B Kokholm, Andreas W Nielsen, Ib T Hansen, et al.
Frontiers in Medicine|July 19, 2024
The DANIsh VASculitis cohort study: protocol for a national multicenter prospective study including incident and prevalent patients with giant cell arteritis and polymyalgia rheumaticaBerit D Nielsen, Salome Kristensen, Agnete Donskov, et al.
Pageof 2